

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.45178514 |
| 2 | nuclear pore organization (GO:0006999) | 6.41283301 |
| 3 | pore complex assembly (GO:0046931) | 5.59232573 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 4.99710581 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 4.92066123 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.65693778 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.65693778 |
| 8 | mitotic sister chromatid cohesion (GO:0007064) | 4.37863334 |
| 9 | ribosome assembly (GO:0042255) | 4.37056813 |
| 10 | mitotic nuclear envelope disassembly (GO:0007077) | 4.32534149 |
| 11 | mitotic metaphase plate congression (GO:0007080) | 4.24025329 |
| 12 | mitotic chromosome condensation (GO:0007076) | 4.18376278 |
| 13 | membrane disassembly (GO:0030397) | 4.14532495 |
| 14 | nuclear envelope disassembly (GO:0051081) | 4.14532495 |
| 15 | establishment of viral latency (GO:0019043) | 4.14407528 |
| 16 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.13249945 |
| 17 | mitotic sister chromatid segregation (GO:0000070) | 4.02196852 |
| 18 | protein localization to chromosome, centromeric region (GO:0071459) | 4.01903062 |
| 19 | DNA strand elongation (GO:0022616) | 4.01524675 |
| 20 | sister chromatid segregation (GO:0000819) | 3.98622122 |
| 21 | protein localization to kinetochore (GO:0034501) | 3.85267995 |
| 22 | negative regulation of DNA repair (GO:0045738) | 3.79917643 |
| 23 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.77875482 |
| 24 | metaphase plate congression (GO:0051310) | 3.76872897 |
| 25 | establishment of chromosome localization (GO:0051303) | 3.66289912 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.63888109 |
| 27 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.61549165 |
| 28 | non-recombinational repair (GO:0000726) | 3.61549165 |
| 29 | COPII vesicle coating (GO:0048208) | 3.58901368 |
| 30 | spindle checkpoint (GO:0031577) | 3.54940033 |
| 31 | DNA ligation (GO:0006266) | 3.49990335 |
| 32 | regulation of chromosome segregation (GO:0051983) | 3.47956249 |
| 33 | mitotic spindle checkpoint (GO:0071174) | 3.47323165 |
| 34 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44446066 |
| 35 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.41598121 |
| 36 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.41598121 |
| 37 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.41598121 |
| 38 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.41598121 |
| 39 | negative regulation of sister chromatid segregation (GO:0033046) | 3.41598121 |
| 40 | negative regulation of chromosome segregation (GO:0051985) | 3.39010356 |
| 41 | DNA duplex unwinding (GO:0032508) | 3.38439748 |
| 42 | mitotic spindle assembly checkpoint (GO:0007094) | 3.34061428 |
| 43 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.31672286 |
| 44 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.31672286 |
| 45 | regulation of spindle organization (GO:0090224) | 3.28648206 |
| 46 | DNA geometric change (GO:0032392) | 3.27884281 |
| 47 | spindle assembly checkpoint (GO:0071173) | 3.27346518 |
| 48 | mitotic recombination (GO:0006312) | 3.27139514 |
| 49 | regulation of centriole replication (GO:0046599) | 3.26977617 |
| 50 | DNA replication initiation (GO:0006270) | 3.21506252 |
| 51 | regulation of mitotic spindle organization (GO:0060236) | 3.20513176 |
| 52 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.17607064 |
| 53 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.17607064 |
| 54 | regulation of sister chromatid segregation (GO:0033045) | 3.17607064 |
| 55 | regulation of histone H3-K9 methylation (GO:0051570) | 3.14408300 |
| 56 | regulation of sister chromatid cohesion (GO:0007063) | 3.13608914 |
| 57 | telomere maintenance via recombination (GO:0000722) | 3.12532868 |
| 58 | DNA topological change (GO:0006265) | 3.11157401 |
| 59 | formation of translation preinitiation complex (GO:0001731) | 3.10762839 |
| 60 | proteasome assembly (GO:0043248) | 3.10739535 |
| 61 | nuclear envelope organization (GO:0006998) | 3.08614964 |
| 62 | regulation of translational fidelity (GO:0006450) | 3.05986667 |
| 63 | CENP-A containing nucleosome assembly (GO:0034080) | 3.05905036 |
| 64 | IMP biosynthetic process (GO:0006188) | 3.03349720 |
| 65 | regulation of RNA export from nucleus (GO:0046831) | 2.99941846 |
| 66 | positive regulation of chromosome segregation (GO:0051984) | 2.97737512 |
| 67 | DNA conformation change (GO:0071103) | 2.96316669 |
| 68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91693525 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91070728 |
| 70 | DNA synthesis involved in DNA repair (GO:0000731) | 2.89448044 |
| 71 | DNA replication checkpoint (GO:0000076) | 2.89332491 |
| 72 | vesicle coating (GO:0006901) | 2.89192816 |
| 73 | chromosome segregation (GO:0007059) | 2.87304184 |
| 74 | chromosome condensation (GO:0030261) | 2.84822939 |
| 75 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.84802035 |
| 76 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.84432552 |
| 77 | regulation of DNA endoreduplication (GO:0032875) | 2.82151349 |
| 78 | chromatin remodeling at centromere (GO:0031055) | 2.79538816 |
| 79 | protein export from nucleus (GO:0006611) | 2.78589618 |
| 80 | IMP metabolic process (GO:0046040) | 2.77799070 |
| 81 | mitotic G2/M transition checkpoint (GO:0044818) | 2.74857101 |
| 82 | tRNA aminoacylation for protein translation (GO:0006418) | 2.72232814 |
| 83 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70526352 |
| 84 | negative regulation of mitosis (GO:0045839) | 2.68722299 |
| 85 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.68162243 |
| 86 | response to X-ray (GO:0010165) | 2.67037555 |
| 87 | DNA packaging (GO:0006323) | 2.66752024 |
| 88 | protein localization to chromosome (GO:0034502) | 2.65418998 |
| 89 | tRNA aminoacylation (GO:0043039) | 2.65301252 |
| 90 | amino acid activation (GO:0043038) | 2.65301252 |
| 91 | protein complex localization (GO:0031503) | 2.64980228 |
| 92 | purine nucleobase biosynthetic process (GO:0009113) | 2.64877817 |
| 93 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.62645398 |
| 94 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.62160206 |
| 95 | RNA-dependent DNA replication (GO:0006278) | 2.61971401 |
| 96 | telomere maintenance via telomere lengthening (GO:0010833) | 2.61613112 |
| 97 | kinetochore organization (GO:0051383) | 2.60921252 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.59956087 |
| 99 | negative regulation of ligase activity (GO:0051352) | 2.59956087 |
| 100 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.56714613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.43874802 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.90341592 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.86999421 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.11476808 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.11349919 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.05682522 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90766949 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.87534673 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75852597 |
| 10 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.63054964 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.40312132 |
| 12 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25738665 |
| 13 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.25579340 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23732073 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.22410549 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.20002032 |
| 17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.19754890 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.13351786 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07712246 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.07144172 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98684792 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.98646256 |
| 23 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.98321344 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96610418 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.90712506 |
| 26 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.89681439 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.88881643 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.83109183 |
| 29 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.81680404 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78296974 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.70152239 |
| 32 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68690075 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68629494 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67824365 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65981415 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62857206 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61848750 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.57947016 |
| 39 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56577779 |
| 40 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54381505 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50544665 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.45929216 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.45865489 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43474949 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39622518 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39220697 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38411919 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35746670 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33218134 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32950358 |
| 51 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.31218802 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31033490 |
| 53 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.30294952 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28704757 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28585469 |
| 56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25911135 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.24272556 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22256967 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21892746 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21426080 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20790351 |
| 62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19180683 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18956143 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18636867 |
| 65 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18599456 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17164505 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15395092 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14641750 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12361310 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11726303 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08255899 |
| 72 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06739773 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06200725 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02976803 |
| 75 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02887426 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00026523 |
| 77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.99847003 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99553560 |
| 79 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99022297 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97512489 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94995220 |
| 82 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94150919 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92146585 |
| 84 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91684175 |
| 85 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87798456 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86928230 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86841830 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86841830 |
| 89 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86177740 |
| 90 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85913182 |
| 91 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85622424 |
| 92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85507783 |
| 93 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85433789 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84644114 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84010967 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.80763936 |
| 97 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80496413 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.80116943 |
| 99 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.79415103 |
| 100 | MYC_22102868_ChIP-Seq_BL_Human | 0.78922393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.38576320 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.77427304 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.50914451 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.50805436 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.37428413 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.01021923 |
| 7 | MP0003077_abnormal_cell_cycle | 2.99471825 |
| 8 | MP0003941_abnormal_skin_development | 2.90407641 |
| 9 | MP0009697_abnormal_copulation | 2.82047263 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.80808285 |
| 11 | MP0008058_abnormal_DNA_repair | 2.73369298 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.59912356 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.21677300 |
| 14 | MP0005408_hypopigmentation | 2.00892520 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.00038978 |
| 16 | MP0002396_abnormal_hematopoietic_system | 1.99762014 |
| 17 | MP0001730_embryonic_growth_arrest | 1.93499952 |
| 18 | MP0000350_abnormal_cell_proliferation | 1.83133316 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.80898418 |
| 20 | MP0005380_embryogenesis_phenotype | 1.65533155 |
| 21 | MP0001672_abnormal_embryogenesis/_devel | 1.65533155 |
| 22 | MP0004272_abnormal_basement_membrane | 1.65332443 |
| 23 | MP0003718_maternal_effect | 1.64388420 |
| 24 | MP0006054_spinal_hemorrhage | 1.64302283 |
| 25 | MP0010307_abnormal_tumor_latency | 1.63813855 |
| 26 | MP0003984_embryonic_growth_retardation | 1.60624192 |
| 27 | MP0001697_abnormal_embryo_size | 1.57037517 |
| 28 | MP0003786_premature_aging | 1.55431369 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.55357544 |
| 30 | MP0002088_abnormal_embryonic_growth/wei | 1.54636551 |
| 31 | MP0008260_abnormal_autophagy | 1.53907991 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.52705668 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.46396035 |
| 34 | MP0002086_abnormal_extraembryonic_tissu | 1.45951881 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.44499072 |
| 36 | MP0002080_prenatal_lethality | 1.44017466 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.43454333 |
| 38 | MP0001915_intracranial_hemorrhage | 1.42987182 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.35832970 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.34384383 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.31778364 |
| 42 | MP0004233_abnormal_muscle_weight | 1.31493340 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.29994869 |
| 44 | MP0005257_abnormal_intraocular_pressure | 1.28963709 |
| 45 | MP0002009_preneoplasia | 1.25923738 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.23576529 |
| 47 | MP0000313_abnormal_cell_death | 1.21710778 |
| 48 | MP0005621_abnormal_cell_physiology | 1.21279258 |
| 49 | MP0002084_abnormal_developmental_patter | 1.19706405 |
| 50 | MP0000358_abnormal_cell_content/ | 1.16684478 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16613395 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.15121006 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.13584915 |
| 54 | MP0009672_abnormal_birth_weight | 1.13415604 |
| 55 | MP0005384_cellular_phenotype | 1.13157283 |
| 56 | MP0001661_extended_life_span | 1.11571004 |
| 57 | MP0002006_tumorigenesis | 1.10949755 |
| 58 | MP0008877_abnormal_DNA_methylation | 1.08460516 |
| 59 | MP0002060_abnormal_skin_morphology | 1.03648233 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.01397557 |
| 61 | MP0001853_heart_inflammation | 0.98987767 |
| 62 | MP0005275_abnormal_skin_tensile | 0.98566148 |
| 63 | MP0002085_abnormal_embryonic_tissue | 0.98472620 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.93022011 |
| 65 | MP0005451_abnormal_body_composition | 0.92343225 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 0.90373440 |
| 67 | MP0004197_abnormal_fetal_growth/weight/ | 0.89793745 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.88966961 |
| 69 | MP0005023_abnormal_wound_healing | 0.86119817 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82925808 |
| 71 | MP0005395_other_phenotype | 0.82088304 |
| 72 | MP0000371_diluted_coat_color | 0.81295348 |
| 73 | MP0003868_abnormal_feces_composition | 0.79520132 |
| 74 | MP0005501_abnormal_skin_physiology | 0.74529010 |
| 75 | MP0003186_abnormal_redox_activity | 0.72815272 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.72780093 |
| 77 | MP0001666_abnormal_nutrient_absorption | 0.71945590 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.71297022 |
| 79 | MP0005197_abnormal_uvea_morphology | 0.69716024 |
| 80 | MP0009703_decreased_birth_body | 0.69208637 |
| 81 | MP0003315_abnormal_perineum_morphology | 0.69181651 |
| 82 | MP0000627_abnormal_mammary_gland | 0.69107840 |
| 83 | MP0000598_abnormal_liver_morphology | 0.68028937 |
| 84 | MP0002796_impaired_skin_barrier | 0.67969358 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.67112683 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.65591022 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 0.65400770 |
| 88 | MP0001929_abnormal_gametogenesis | 0.58222022 |
| 89 | MP0003091_abnormal_cell_migration | 0.58170275 |
| 90 | MP0000609_abnormal_liver_physiology | 0.58107786 |
| 91 | MP0001243_abnormal_dermal_layer | 0.56468276 |
| 92 | MP0001191_abnormal_skin_condition | 0.56224545 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.55788791 |
| 94 | MP0002722_abnormal_immune_system | 0.55787928 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.54959169 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.54809352 |
| 97 | MP0002210_abnormal_sex_determination | 0.52469418 |
| 98 | MP0000490_abnormal_crypts_of | 0.52355605 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.52349806 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.52281163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromsome breakage (HP:0040012) | 4.27866951 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.08715727 |
| 3 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.37602145 |
| 4 | Abnormality of chromosome stability (HP:0003220) | 3.30150130 |
| 5 | Abnormality of glycolysis (HP:0004366) | 3.25960570 |
| 6 | Embryonal renal neoplasm (HP:0011794) | 3.25490749 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.21241931 |
| 8 | Medulloblastoma (HP:0002885) | 3.16729418 |
| 9 | Papillary thyroid carcinoma (HP:0002895) | 3.00018943 |
| 10 | Reduced antithrombin III activity (HP:0001976) | 2.95572667 |
| 11 | Abnormality of the preputium (HP:0100587) | 2.91574934 |
| 12 | Deep philtrum (HP:0002002) | 2.84461060 |
| 13 | Microglossia (HP:0000171) | 2.76723911 |
| 14 | Multiple enchondromatosis (HP:0005701) | 2.73215661 |
| 15 | Increased nuchal translucency (HP:0010880) | 2.68864508 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 2.61054877 |
| 17 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.59730149 |
| 18 | Osteolytic defects of the hand bones (HP:0009699) | 2.59730149 |
| 19 | Insidious onset (HP:0003587) | 2.57098572 |
| 20 | Termporal pattern (HP:0011008) | 2.57098572 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 2.56639520 |
| 22 | Myelodysplasia (HP:0002863) | 2.56440666 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53607488 |
| 24 | Acute myeloid leukemia (HP:0004808) | 2.50730105 |
| 25 | Rhabdomyosarcoma (HP:0002859) | 2.43492821 |
| 26 | Orthostatic hypotension (HP:0001278) | 2.37940339 |
| 27 | Small intestinal stenosis (HP:0012848) | 2.35191327 |
| 28 | Duodenal stenosis (HP:0100867) | 2.35191327 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.33413101 |
| 30 | Ankyloglossia (HP:0010296) | 2.31187582 |
| 31 | Meckel diverticulum (HP:0002245) | 2.29352485 |
| 32 | Progressive external ophthalmoplegia (HP:0000590) | 2.28185708 |
| 33 | Deviation of the thumb (HP:0009603) | 2.23147650 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.23038599 |
| 35 | Thyroid carcinoma (HP:0002890) | 2.20858095 |
| 36 | Acanthocytosis (HP:0001927) | 2.18315449 |
| 37 | Cortical dysplasia (HP:0002539) | 2.18228357 |
| 38 | Proximal placement of thumb (HP:0009623) | 2.14990809 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13976705 |
| 40 | Freckling (HP:0001480) | 2.12700825 |
| 41 | Abnormal foot bone ossification (HP:0010675) | 2.10465529 |
| 42 | Entropion (HP:0000621) | 2.09331795 |
| 43 | Neoplasm of the small intestine (HP:0100833) | 2.08540347 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.08353525 |
| 45 | Uterine leiomyosarcoma (HP:0002891) | 2.07377966 |
| 46 | Leiomyosarcoma (HP:0100243) | 2.07377966 |
| 47 | Abnormality of the ileum (HP:0001549) | 2.05193730 |
| 48 | Secondary amenorrhea (HP:0000869) | 2.03612756 |
| 49 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02412693 |
| 50 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02412693 |
| 51 | Abnormal protein glycosylation (HP:0012346) | 2.02412693 |
| 52 | Abnormal glycosylation (HP:0012345) | 2.02412693 |
| 53 | Gastrointestinal carcinoma (HP:0002672) | 2.01901258 |
| 54 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.01901258 |
| 55 | Volvulus (HP:0002580) | 2.01492691 |
| 56 | Neoplasm of the colon (HP:0100273) | 2.01186572 |
| 57 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98240056 |
| 58 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.97608109 |
| 59 | Abnormal auditory evoked potentials (HP:0006958) | 1.94876901 |
| 60 | Fatigue (HP:0012378) | 1.94361544 |
| 61 | Neoplasm of the rectum (HP:0100743) | 1.91963356 |
| 62 | Cafe-au-lait spot (HP:0000957) | 1.91238595 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 1.90967429 |
| 64 | Cholecystitis (HP:0001082) | 1.90967429 |
| 65 | Ependymoma (HP:0002888) | 1.90051850 |
| 66 | Syringomyelia (HP:0003396) | 1.89652656 |
| 67 | Spinal cord lesions (HP:0100561) | 1.89652656 |
| 68 | Intrahepatic cholestasis (HP:0001406) | 1.89431210 |
| 69 | Ovarian neoplasm (HP:0100615) | 1.86704543 |
| 70 | Abnormal lung lobation (HP:0002101) | 1.85875239 |
| 71 | Cutaneous melanoma (HP:0012056) | 1.85783859 |
| 72 | Abnormality of oral frenula (HP:0000190) | 1.84268855 |
| 73 | Relative macrocephaly (HP:0004482) | 1.82581889 |
| 74 | Premature rupture of membranes (HP:0001788) | 1.82210626 |
| 75 | Uterine neoplasm (HP:0010784) | 1.81126586 |
| 76 | Birth length less than 3rd percentile (HP:0003561) | 1.80131234 |
| 77 | Increased mean platelet volume (HP:0011877) | 1.78575255 |
| 78 | Capillary hemangiomas (HP:0005306) | 1.78435259 |
| 79 | Overlapping toe (HP:0001845) | 1.77477615 |
| 80 | Abnormality of the duodenum (HP:0002246) | 1.76771196 |
| 81 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.76432290 |
| 82 | Hypolipoproteinemia (HP:0010981) | 1.75940302 |
| 83 | Asymmetry of the thorax (HP:0001555) | 1.74762064 |
| 84 | Autoamputation (HP:0001218) | 1.74721441 |
| 85 | Selective tooth agenesis (HP:0001592) | 1.73585346 |
| 86 | Spastic diplegia (HP:0001264) | 1.72964718 |
| 87 | Poikiloderma (HP:0001029) | 1.72455409 |
| 88 | Horizontal nystagmus (HP:0000666) | 1.65979884 |
| 89 | IgA deficiency (HP:0002720) | 1.65807201 |
| 90 | Hypoplastic pelvis (HP:0008839) | 1.63196081 |
| 91 | Abnormal cartilage morphology (HP:0002763) | 1.60187185 |
| 92 | Embryonal neoplasm (HP:0002898) | 1.59714111 |
| 93 | Biliary tract neoplasm (HP:0100574) | 1.59531412 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.59393492 |
| 95 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59137310 |
| 96 | Prolonged partial thromboplastin time (HP:0003645) | 1.58311852 |
| 97 | Bladder carcinoma (HP:0002862) | 1.58063935 |
| 98 | Bladder neoplasm (HP:0009725) | 1.58063935 |
| 99 | Prominent nose (HP:0000448) | 1.56863696 |
| 100 | Abnormality of the carotid arteries (HP:0005344) | 1.55204555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 3.48799406 |
| 2 | BUB1 | 3.44731216 |
| 3 | EIF2AK1 | 3.43392517 |
| 4 | PBK | 3.21239414 |
| 5 | TTK | 3.12073452 |
| 6 | NEK1 | 2.99851121 |
| 7 | CDC7 | 2.90171271 |
| 8 | SRPK1 | 2.85873155 |
| 9 | EIF2AK3 | 2.72562299 |
| 10 | TSSK6 | 2.62413993 |
| 11 | MST4 | 2.55344392 |
| 12 | PLK4 | 1.97184717 |
| 13 | BRSK2 | 1.96081753 |
| 14 | PDK2 | 1.94447958 |
| 15 | NME2 | 1.85106575 |
| 16 | PLK3 | 1.83069676 |
| 17 | TAF1 | 1.82275011 |
| 18 | CDK12 | 1.77332152 |
| 19 | VRK2 | 1.72709338 |
| 20 | WEE1 | 1.69075411 |
| 21 | MST1R | 1.66322970 |
| 22 | MET | 1.57825352 |
| 23 | LATS1 | 1.50576689 |
| 24 | MKNK1 | 1.46625061 |
| 25 | NEK9 | 1.40388001 |
| 26 | PLK1 | 1.24319838 |
| 27 | STK10 | 1.20299314 |
| 28 | PAK4 | 1.20023109 |
| 29 | CDK7 | 1.16830636 |
| 30 | MAP3K12 | 1.16176322 |
| 31 | CDK6 | 1.14195622 |
| 32 | EEF2K | 1.13165539 |
| 33 | PDGFRA | 1.12676402 |
| 34 | STK3 | 1.07465305 |
| 35 | STK16 | 1.05605997 |
| 36 | BRSK1 | 1.04765996 |
| 37 | ATR | 1.02210216 |
| 38 | AURKB | 1.02168705 |
| 39 | CHEK2 | 1.01534453 |
| 40 | MAP3K10 | 1.00838009 |
| 41 | FLT3 | 0.98372584 |
| 42 | CHEK1 | 0.97882123 |
| 43 | MELK | 0.97739225 |
| 44 | ERBB4 | 0.96285091 |
| 45 | MAP3K8 | 0.91330447 |
| 46 | SMG1 | 0.89540517 |
| 47 | BRD4 | 0.89036398 |
| 48 | RPS6KB2 | 0.88633056 |
| 49 | VRK1 | 0.88534413 |
| 50 | STK4 | 0.88310469 |
| 51 | ATM | 0.87202893 |
| 52 | TESK2 | 0.84026523 |
| 53 | RAF1 | 0.79246318 |
| 54 | YES1 | 0.78645402 |
| 55 | CDK4 | 0.78440828 |
| 56 | PNCK | 0.75250091 |
| 57 | EIF2AK2 | 0.74745543 |
| 58 | NEK2 | 0.72670655 |
| 59 | MKNK2 | 0.71076477 |
| 60 | TRIM28 | 0.69642127 |
| 61 | MAP2K3 | 0.69113310 |
| 62 | PASK | 0.67800891 |
| 63 | AKT3 | 0.66896283 |
| 64 | CLK1 | 0.65628561 |
| 65 | ALK | 0.65295141 |
| 66 | ZAK | 0.63334477 |
| 67 | FGFR1 | 0.62700605 |
| 68 | KSR2 | 0.59435537 |
| 69 | CAMK1G | 0.57812346 |
| 70 | ERBB3 | 0.57013766 |
| 71 | MAP3K14 | 0.55548458 |
| 72 | NEK6 | 0.54921518 |
| 73 | NUAK1 | 0.53914374 |
| 74 | BRAF | 0.53021439 |
| 75 | MAP3K5 | 0.52791010 |
| 76 | LATS2 | 0.51942532 |
| 77 | MAP3K2 | 0.50715379 |
| 78 | PKN2 | 0.50474009 |
| 79 | CCNB1 | 0.48777602 |
| 80 | TRPM7 | 0.46038816 |
| 81 | PRPF4B | 0.45846018 |
| 82 | FGFR4 | 0.45691470 |
| 83 | TEC | 0.45209784 |
| 84 | CDK1 | 0.44941883 |
| 85 | AURKA | 0.44516104 |
| 86 | CDK8 | 0.44029528 |
| 87 | MAPKAPK5 | 0.43875659 |
| 88 | BMX | 0.42429365 |
| 89 | STK38L | 0.41695099 |
| 90 | CSNK2A2 | 0.41220810 |
| 91 | BCR | 0.39984817 |
| 92 | CDK2 | 0.38996840 |
| 93 | MAP3K6 | 0.38571297 |
| 94 | CDK9 | 0.37732543 |
| 95 | RET | 0.36305859 |
| 96 | PLK2 | 0.35549664 |
| 97 | KSR1 | 0.35516651 |
| 98 | STK24 | 0.35123255 |
| 99 | CSNK1A1L | 0.34365393 |
| 100 | PTK2 | 0.34201990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.72468842 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.59464524 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.40089990 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.02347103 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.91522252 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.89302045 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.86717424 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.71490837 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.31631842 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.24720777 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99611036 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.89327485 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.88679668 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.86033775 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.77287288 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.70470797 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62446968 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61395737 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57069973 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.56708470 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47730377 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35189963 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32411413 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.31152260 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28331795 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26114863 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23258234 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23176541 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22916314 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22455227 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18389256 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15098082 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13866176 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12170498 |
| 35 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.12032030 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.07166118 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.04162129 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04126617 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02784164 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02136105 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.00692854 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99281367 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93671471 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92803781 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91994771 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91729330 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91083125 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90961258 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88738277 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84148460 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.76749181 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75874760 |
| 53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74562961 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73841573 |
| 55 | Prostate cancer_Homo sapiens_hsa05215 | 0.73635191 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72860748 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70356257 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.70331568 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70292030 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68175452 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67663398 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63752111 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.63516108 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.62659560 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62479621 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62373078 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62296506 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57936939 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57625580 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57014459 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.54783465 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.54743455 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54678980 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52044205 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49013059 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.48598819 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.47543231 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46542273 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45165927 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43203688 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.41814474 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39491048 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39055641 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38639113 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37695478 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.36913710 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34847051 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33821346 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33558410 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33336763 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30427052 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30425838 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30338712 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30112910 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29876570 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29416224 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29403379 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27745759 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26641817 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26178342 |

